💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak, stagnant business, fully valued.
Aster DM Healthcare is scored on the pharma / healthcare framework. It keeps a slim 9.0% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.54× reported profit. Free cash flow is worth about 0.6% of its market value.
Over the last 3 years revenue compounded at 16%/yr and profit at -4%/yr. Book value has been broadly flat (-0.2%/yr). Return on equity is a modest 8.5%. In the latest quarter profit fell 81% versus the prior quarter.
At 95× earnings, the stock sits at the 61st percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price already implies ~39%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 171.37 | 75.46 | worse |
| P/B | 14.77 | 3.5 | worse |
| EV/EBITDA | 70.29 | 19.83 | worse |
| ROE | 8.48 | — | — |
| ROCE | 10.1 | 10.78 | worse |
| ROA | 4.47 | 3.84 | better |
| Quick Ratio | 1.9 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Revenue has grown every year across all 4 financial years shown. 16% CAGR over 3 years — steady double-digit compounder.
Revenue is outpacing profit (16% vs -4%) — costs are rising faster than the top line. The latest year saw a -92% swing — check if it's a one-off or structural.
Operating margin has expanded from 6% to 12% — the business is keeping more of each rupee earned. The gap between operating and net margin is widening — interest or tax costs are rising.
ROE at 9% — modest; the capital isn't working hard. Capital efficiency improving — ROE up 6pp across the window.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. -4% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.5× PAT — earnings are well-backed by cash; strong accrual quality. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 11% sequentially — momentum is building. Low quarterly variance (10% spread) — a predictable, non-seasonal revenue stream.
Profit fell 81% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly margins are compressing (10% → 2%) — more revenue isn't translating to proportionally more profit.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoter holding at 53.8% — majority control intact. Promoters added 13.4pp over 4 quarters — creeping acquisition signals conviction. FIIs trimmed 4.9pp — foreign money is rotating out. MF stake down 5.7pp — domestic funds are booking profits or rebalancing out.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.